Second-site proviral enhancer alterations in lymphomas induced by enhancer mutants of SL3-3 murine leukemia virus: negative effect of nuclear factor 1 binding site.

Podobne zapisy

• Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
  od: Ethelberg, S, i wsp.
  Wydane: (1997)
• SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus.
  od: Hallberg, B, i wsp.
  Wydane: (1991)
• Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
  od: Amtoft, H W, i wsp.
  Wydane: (1997)
• Replication and Pathogenicity of Primer Binding Site Mutants of SL3-3 Murine Leukemia Viruses
  od: Lund, Anders H., i wsp.
  Wydane: (1999)
• Mutant analysis of protein interactions with a nuclear factor I binding site in the SL3-3 virus enhancer.
  od: Nilsson, P, i wsp.
  Wydane: (1989)